1. Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal

   • Hiroyuki Takamatsu
   • Takeshi Yoroidaka

   Images in Hematology 23 November 2021 Pages: 1 - 2

   

2. Hairy kidney in high-grade B-cell lymphoma

   • Verónica Roldán Galiacho
   • Javier Arzuaga-Méndez
   • Juan Carlos García-Ruiz

   Images in Hematology 09 November 2021 Pages: 3 - 4

   

3. Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma

   • Chen-lu Yang
   • Xin-rong Xiang
   • Yu Wu

   Images in Hematology 11 November 2021 Pages: 5 - 6

   

4. Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

   • Yohei Funakoshi
   • Kimikazu Yakushijin
   • Hironobu Minami

   Rapid Communication 04 January 2022 Pages: 7 - 10

   

5. Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan

   • Masahiro Ieko
   • Kazumasa Ohmura
   • Akitada Ichinose

   Original Article 02 September 2021 Pages: 11 - 20

   

6. Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance

   • Wenmin Han
   • Feng Zhou
   • Xuzhang Lu

   Original Article 27 August 2021 Pages: 21 - 32

   

7. Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

   • Hirohisa Nakamae
   • Masahide Yamamoto
   • Hirohiko Shibayama

   Original Article 11 September 2021 Pages: 33 - 42

   

8. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16

   • Vilma Dembitz
   • Hrvoje Lalic
   • Dora Visnjic

   Original Article 21 September 2021 Pages: 43 - 53

   

9. Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma

   • Laura Galvez-Carvajal
   • Cristina Quero
   • Antonio Rueda

   Original Article 21 September 2021 Pages: 54 - 60

   

10. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

    • Ignacio Gómez-Centurión
    • Gillen Oarbeascoa
    • Mi Kwon

    Original Article 22 September 2021 Pages: 61 - 68

    

11. A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation

    • Akihiko Izumi
    • Takayoshi Tachibana
    • Hideaki Nakajima

    Original Article 06 September 2021 Pages: 69 - 76

    

12. A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation

    • Hirohisa Nakamae
    • Takahiko Nakane
    • Masayuki Hino

    Original Article 29 September 2021 Pages: 77 - 86

    

13. Relationship between serum zinc level and sepsis-induced coagulopathy

    • Yuhei Irie
    • Kota Hoshino
    • Hiroyasu Ishikura

    Original Article 20 October 2021 Pages: 87 - 95

    

14. Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

    • Fumiaki Jinnouchi
    • Yasuo Mori
    • Katsuto Takenaka

    Original Article 15 October 2021 Pages: 96 - 106

    

15. Red blood cell exchange in children with sickle cell disease

    • Narcisse Elenga
    • Vincent Vantilcke
    • Thierry Basset

    Original Article 22 September 2021 Pages: 107 - 113

    

16. Favorable prognosis of vaccine-associated immune thrombocytopenia in children is correlated with young age at vaccination: Retrospective survey of a nationwide disease registry

    • Junichi Kitazawa
    • Hisaya Nakadate
    • Platelet Committee of the Japanese Society of Pediatric Hematology/Oncology

    Original Article 09 October 2021 Pages: 114 - 122

    

17. Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan

    • Akira Hayakawa
    • Iori Sato
    • Shinichiro Okamoto

    Original Article 03 October 2021 Pages: 123 - 128

    

18. Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease

    • Hajime Kaga
    • Honami Kurahashi
    • Naoto Takahashi

    Case Report 30 September 2021 Pages: 129 - 134

    

19. Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study

    • Seung-Hwan Lee
    • Jae-Ho Yoon
    • Seok Lee

    Case Report 06 October 2021 Pages: 135 - 139

    

20. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation

    • Takaya Honda
    • Masayoshi Yamaoka
    • Masaharu Akiyama

    Case Report 30 September 2021 Pages: 140 - 145

    

21. Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation

    • Hirohisa Nakamae
    • Takahiko Nakane
    • Masayuki Hino

    Correction 01 November 2021 Pages: 146 - 146

22. Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation

    • Lingyu Zeng
    • Shuang Ding
    • Kailin Xu

    Correction 29 November 2021 Pages: 147 - 148